These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 25463412)

  • 21. Serial measurement of galectin-3 in patients with chronic heart failure: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study.
    Motiwala SR; Szymonifka J; Belcher A; Weiner RB; Baggish AL; Sluss P; Gaggin HK; Bhardwaj A; Januzzi JL
    Eur J Heart Fail; 2013 Oct; 15(10):1157-63. PubMed ID: 23666680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community.
    Ho JE; Liu C; Lyass A; Courchesne P; Pencina MJ; Vasan RS; Larson MG; Levy D
    J Am Coll Cardiol; 2012 Oct; 60(14):1249-56. PubMed ID: 22939561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biomarkers and low risk in heart failure. Data from COACH and TRIUMPH.
    Meijers WC; de Boer RA; van Veldhuisen DJ; Jaarsma T; Hillege HL; Maisel AS; Di Somma S; Voors AA; Peacock WF
    Eur J Heart Fail; 2015 Dec; 17(12):1271-82. PubMed ID: 26466857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of short-term follow-up BNP in hospitalized patients with heart failure.
    Khanam SS; Son JW; Lee JW; Youn YJ; Yoon J; Lee SH; Kim JY; Ahn SG; Ahn MS; Yoo BS
    BMC Cardiovasc Disord; 2017 Aug; 17(1):215. PubMed ID: 28774268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive value of galectin-3 for incident cardiovascular disease and heart failure in the population-based FINRISK 1997 cohort.
    Jagodzinski A; Havulinna AS; Appelbaum S; Zeller T; Jousilahti P; Skytte-Johanssen S; Hughes MF; Blankenberg S; Salomaa V
    Int J Cardiol; 2015 Aug; 192():33-9. PubMed ID: 25985013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Galectin-3 is independently associated with cardiovascular mortality in community-dwelling older adults without known cardiovascular disease: The Rancho Bernardo Study.
    Daniels LB; Clopton P; Laughlin GA; Maisel AS; Barrett-Connor E
    Am Heart J; 2014 May; 167(5):674-82.e1. PubMed ID: 24766977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of plasma galectin-3 levels in patients with coronary heart disease and chronic heart failure.
    Yu X; Sun Y; Zhao Y; Zhang W; Yang Z; Gao Y; Cai H; Li Y; Wang Q; Bian B; Nie J
    Int Heart J; 2015 May; 56(3):314-8. PubMed ID: 25902879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic profile provides prognostic value better than galectin-3 in patients with heart failure.
    Wang CH; Cheng ML; Liu MH; Kuo LT; Shiao MS
    J Cardiol; 2017 Jul; 70(1):92-98. PubMed ID: 28318874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of Galectin-3 Concentrations with the Treatment Effects of β-Blockers and RAS Blockade in Patients with Systolic Heart Failure: A Derivation-Validation Study from TIME-CHF and GISSI-HF.
    Sanders-van Wijk S; Masson S; Milani V; Rickenbacher P; Gorini M; Tavazzi LT; Tobler D; Rickli H; Latini R; Brunner-La Roccaenen HP;
    Clin Chem; 2016 Apr; 62(4):605-16. PubMed ID: 26936932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic and prognostic accuracy of galectin-3 and soluble ST2 for acute heart failure.
    Mueller T; Gegenhuber A; Leitner I; Poelz W; Haltmayer M; Dieplinger B
    Clin Chim Acta; 2016 Dec; 463():158-164. PubMed ID: 27983996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study.
    Lok DJ; Van Der Meer P; de la Porte PW; Lipsic E; Van Wijngaarden J; Hillege HL; van Veldhuisen DJ
    Clin Res Cardiol; 2010 May; 99(5):323-8. PubMed ID: 20130888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of growth differentiation factor-15 in Chinese patients with heart failure: A prospective observational study.
    Wang H; Chen Q; Li Y; Jing X; Yang J
    Cardiol J; 2018; 25(2):245-253. PubMed ID: 28612904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic Value of Galectin-3 for Adverse Outcomes in Chronic Heart Failure.
    French B; Wang L; Ky B; Brandimarto J; Basuray A; Fang JC; Sweitzer NK; Cappola TP
    J Card Fail; 2016 Apr; 22(4):256-62. PubMed ID: 26571149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of sST2 and galectin-3 for death relative to renal function in patients hospitalized for heart failure.
    Zhang R; Zhang Y; An T; Guo X; Yin S; Wang Y; Januzzi JL; Cappola TP; Zhang J
    Biomark Med; 2015; 9(5):433-41. PubMed ID: 25985174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meta-Analysis of the Usefulness of Plasma Galectin-3 to Predict the Risk of Mortality in Patients With Heart Failure and in the General Population.
    Imran TF; Shin HJ; Mathenge N; Wang F; Kim B; Joseph J; Gaziano JM; Djoussé L
    Am J Cardiol; 2017 Jan; 119(1):57-64. PubMed ID: 28247849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Galectin-3 as a marker for clinical prognosis and cardiac remodeling in acute heart failure.
    Lala RI; Lungeanu D; Darabantiu D; Pilat L; Puschita M
    Herz; 2018 Mar; 43(2):146-155. PubMed ID: 28235980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Galectin-3 and Risk of Heart Failure and Death in Blacks and Whites.
    McEvoy JW; Chen Y; Halushka MK; Christenson E; Ballantyne CM; Blumenthal RS; Christenson RH; Selvin E
    J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27178204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Galectin-3 Levels and Outcomes After Myocardial Infarction: A Population-Based Study.
    Asleh R; Enriquez-Sarano M; Jaffe AS; Manemann SM; Weston SA; Jiang R; Roger VL
    J Am Coll Cardiol; 2019 May; 73(18):2286-2295. PubMed ID: 31072572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical factors related to morbidity and mortality in high-risk heart failure patients: the GUIDE-IT predictive model and risk score.
    O'Connor C; Fiuzat M; Mulder H; Coles A; Ahmad T; Ezekowitz JA; Adams KF; Piña IL; Anstrom KJ; Cooper LS; Mark DB; Whellan DJ; Januzzi JL; Leifer ES; Felker GM
    Eur J Heart Fail; 2019 Jun; 21(6):770-778. PubMed ID: 30919549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triple head-to-head comparison of fibrotic biomarkers galectin-3, osteopontin and gremlin-1 for long-term prognosis in suspected and proven acute heart failure patients.
    Behnes M; Bertsch T; Weiss C; Ahmad-Nejad P; Akin I; Fastner C; El-Battrawy I; Lang S; Neumaier M; Borggrefe M; Hoffmann U
    Int J Cardiol; 2016 Jan; 203():398-406. PubMed ID: 26539964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.